Shilpa Medicare

{
  "main_header": {
    "sid": 780523,
    "name": "Shilpa Medicare",
    "stock_name": "Shilpa Medicare",
    "full_name": "Shilpa Medicare Ltd",
    "name_url": "stocks-analysis/shilpa-medicare",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "759.60",
    "chg": 19.55,
    "chgp": "2.64%",
    "dir": 1,
    "prev_price": "740.05",
    "mcapval": "14,555.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530549,
    "symbol": "SHILPAMED",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE790G01031",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "02:35 AM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "68.25 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shilpa-medicare-780523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Shilpa Medicare Surges 24.21%: 7 Key Drivers Behind This Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-surges-2421-7-key-drivers-behind-this-weeks-rally-4143394",
        "imagepath": "",
        "date": "2026-08-08 15:09:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.623.30 (+1.92%)</p>\n                    <p><strong>4 Aug:</strong> New 52-week high at Rs.655.6</p>\n                    <p><strong>5 Aug:</strong> Intraday high of Rs.695.05 with 7.34% surge; Q1 FY27 results show 115% profit growth</p>\n                    <p><strong>6 Aug:</strong> New 52-week high at Rs.786.55; Mojo Grade upgraded to Buy</p>\n                    <p><strong>7 Aug:</strong> Quality grade upgraded; stock closes at Rs.759.60 (-0.31%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.623.30</div></div>\n ..."
      },
      {
        "title": "Shilpa Medicare Ltd Upgraded to Buy on Strong Financial and Quality Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shilpa-medicare-ltd-upgraded-to-buy-on-strong-financial-and-quality-improvements-4141178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_mojoScore_4141178.png",
        "date": "2026-08-07 08:23:39",
        "description": "Shilpa Medicare Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical momentum. The pharmaceutical company’s recent quarterly results and sustained market outperformance have driven this positive revision, signalling renewed investor confidence in its growth trajectory and operational strength."
      },
      {
        "title": "Shilpa Medicare Ltd Upgrades Quality Grade Amid Strong Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-upgrades-quality-grade-amid-strong-financial-improvements-4140812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_qualitydot_4140812.png",
        "date": "2026-08-07 08:00:09",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade upgraded from below average to average, reflecting notable improvements in its business fundamentals. The company’s recent financial metrics reveal a mixed but generally positive trend in profitability, leverage, and operational efficiency, prompting a MarketsMOJO upgrade to a Buy rating with a mojo score of 75.0 as of 6 August 2026."
      },
      {
        "title": "Are Shilpa Medicare Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-shilpa-medicare-ltd-latest-results-good-or-bad-4140370",
        "imagepath": "",
        "date": "2026-08-06 19:22:11",
        "description": "Shilpa Medicare Ltd's latest financial results for Q1 FY27 reflect a strong operational performance amidst a challenging pharmaceutical environment. The company reported consolidated net profit of ₹100.88 crores, which represents a significant year-on-year growth of 115.14%. However, there was a sequential decline of 6.41% compared to the previous quarter. \n\nRevenue for the quarter reached ₹465.78 crores, showcasing a year-on-year increase of 44.90% and a sequential growth of 6.59%. This marks the highest quarterly revenue in the company's recent history, indicating robust demand across its product portfolio, particularly in active pharmaceutical ingredients (APIs) and formulations.\n\nThe operating margin, excluding other income, improved to 29.26%, up from 28.51% in the same quarter last year, reflecting effective cost management and operational efficiency. The company also demonstrated strong financial fle..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Shilpa Medicare Ltd to 52-Week High of Rs 786.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-new-52-week-high-at-rs78655-4139972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_priceRelatedfactors_4139972.png",
        "date": "2026-08-06 10:14:47",
        "description": "With a decisive surge to Rs 786.55 on 6 Aug 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, marking an impressive rally of 83.46% over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages."
      },
      {
        "title": "Shilpa Medicare Ltd Surges on High-Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-surges-on-high-value-trading-and-institutional-interest-4139799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_most_active_equities_by_value_4139799.png",
        "date": "2026-08-06 10:01:22",
        "description": "Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading activity and price performance, driven by robust institutional interest and significant value turnover. The stock’s recent upgrade to a Hold rating from Sell by MarketsMOJO, coupled with a strong 6.47% day gain and a new 52-week high, underscores growing investor confidence amid a sustained rally."
      },
      {
        "title": "Shilpa Medicare Ltd Sees Exceptional Volume Surge Amidst Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-sees-exceptional-volume-surge-amidst-strong-price-rally-4139762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_most_active_equities_by_volume_4139762.png",
        "date": "2026-08-06 10:00:39",
        "description": "Shilpa Medicare Ltd (SHILPAMED), a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading volume and price on 6 August 2026, signalling robust investor interest and accumulation. The stock hit a new 52-week high of ₹782.15, outperforming its sector by 7.58% and continuing a strong five-day winning streak that has delivered a 29.24% return over the period."
      },
      {
        "title": "Shilpa Medicare Ltd Surges 7.99% to Day's High of Rs 773.15 — Outperforms Sector by 5.24 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-hits-intraday-high-with-799-surge-on-6-august-2026-4139488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_priceRelatedfactors_4139488.png",
        "date": "2026-08-06 09:32:22",
        "description": "The Sensex edged up 0.23% while Shilpa Medicare Ltd surged 7.99% on 6 Aug 2026, hitting a new 52-week high of Rs 773.15. This 5.24 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Shilpa Medicare Ltd Reports Outstanding Q1 2026 Performance Amid Strong Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shilpa-medicare-ltd-reports-outstanding-q1-2026-performance-amid-strong-market-rally-4138978",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ShilpaMedicareL_fintrenddot_4138978.png",
        "date": "2026-08-06 08:00:19",
        "description": "Shilpa Medicare Ltd has delivered an exceptional quarterly performance for June 2026, marking a significant upgrade in its financial trend from very positive to outstanding. The pharmaceutical and biotechnology company recorded its highest-ever quarterly revenue and profit metrics, reflecting robust operational efficiency and strong market demand amid a challenging sector backdrop."
      }
    ],
    "total": 452,
    "sid": "780523",
    "stock_news_url": "https://www.marketsmojo.com/news/shilpa-medicare-780523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "05-Aug-2026",
      "details": "Audio link of the Investor Conference call for Q1 FY27",
      "source": "BSE"
    },
    {
      "caption": "Final Dividend For The FY 2025-26",
      "datetime": "05-Aug-2026",
      "details": "The record date for determining the shareholders entitled for payment of final dividend for FY 2025-26 if declared at the 39th AGM is Friday 4th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30 June 2026",
      "datetime": "05-Aug-2026",
      "details": "Unaudited standalone and consolidated Financial Results for the Quarter ended 30 June 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has declared <strong>100%</strong> dividend, ex-date: 17 Sep 25",
          "dt": "2025-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:2</strong> stock split, ex-date: 06 Nov 15",
          "dt": "2015-11-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shilpa Medicare Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 03 Oct 25",
          "dt": "2025-10-03",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Shilpa Medicare Surges 24.21%: 7 Key Drivers Behind This Week’s Rally

2026-08-08 15:09:07

Key Events This Week

3 Aug: Stock opens strong at Rs.623.30 (+1.92%)

4 Aug: New 52-week high at Rs.655.6

5 Aug: Intraday high of Rs.695.05 with 7.34% surge; Q1 FY27 results show 115% profit growth

6 Aug: New 52-week high at Rs.786.55; Mojo Grade upgraded to Buy

7 Aug: Quality grade upgraded; stock closes at Rs.759.60 (-0.31%)

Week Open

Rs.623.30

...

Read full news article

Shilpa Medicare Ltd Upgraded to Buy on Strong Financial and Quality Improvements

2026-08-07 08:23:39

Shilpa Medicare Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, quality indicators, and technical momentum. The pharmaceutical company’s recent quarterly results and sustained market outperformance have driven this positive revision, signalling renewed investor confidence in its growth trajectory and operational strength.

Read full news article

Shilpa Medicare Ltd Upgrades Quality Grade Amid Strong Financial Improvements

2026-08-07 08:00:09

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grade upgraded from below average to average, reflecting notable improvements in its business fundamentals. The company’s recent financial metrics reveal a mixed but generally positive trend in profitability, leverage, and operational efficiency, prompting a MarketsMOJO upgrade to a Buy rating with a mojo score of 75.0 as of 6 August 2026.

Read full news article

Are Shilpa Medicare Ltd latest results good or bad?

2026-08-06 19:22:11

Shilpa Medicare Ltd's latest financial results for Q1 FY27 reflect a strong operational performance amidst a challenging pharmaceutical environment. The company reported consolidated net profit of ₹100.88 crores, which represents a significant year-on-year growth of 115.14%. However, there was a sequential decline of 6.41% compared to the previous quarter. Revenue for the quarter reached ₹465.78 crores, showcasing a year-on-year increase of 44.90% and a sequential growth of 6.59%. This marks the highest quarterly revenue in the company's recent history, indicating robust demand across its product portfolio, particularly in active pharmaceutical ingredients (APIs) and formulations. The operating margin, excluding other income, improved to 29.26%, up from 28.51% in the same quarter last year, reflecting effective cost management and operational efficiency. The company also demonstrated strong financial fle...

Read full news article

Broad-Based Technical Strength Lifts Shilpa Medicare Ltd to 52-Week High of Rs 786.55

2026-08-06 10:14:47

With a decisive surge to Rs 786.55 on 6 Aug 2026, Shilpa Medicare Ltd has reached a fresh 52-week high, marking an impressive rally of 83.46% over the past year. This milestone is underscored by a strong alignment of technical indicators and sustained price momentum that has propelled the stock well above its key moving averages.

Read full news article

Shilpa Medicare Ltd Surges on High-Value Trading and Institutional Interest

2026-08-06 10:01:22

Shilpa Medicare Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a remarkable surge in trading activity and price performance, driven by robust institutional interest and significant value turnover. The stock’s recent upgrade to a Hold rating from Sell by MarketsMOJO, coupled with a strong 6.47% day gain and a new 52-week high, underscores growing investor confidence amid a sustained rally.

Read full news article

Shilpa Medicare Ltd Sees Exceptional Volume Surge Amidst Strong Price Rally

2026-08-06 10:00:39

Shilpa Medicare Ltd (SHILPAMED), a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading volume and price on 6 August 2026, signalling robust investor interest and accumulation. The stock hit a new 52-week high of ₹782.15, outperforming its sector by 7.58% and continuing a strong five-day winning streak that has delivered a 29.24% return over the period.

Read full news article

Shilpa Medicare Ltd Surges 7.99% to Day's High of Rs 773.15 — Outperforms Sector by 5.24 Percentage Points

2026-08-06 09:32:22

The Sensex edged up 0.23% while Shilpa Medicare Ltd surged 7.99% on 6 Aug 2026, hitting a new 52-week high of Rs 773.15. This 5.24 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.

Read full news article

Shilpa Medicare Ltd Reports Outstanding Q1 2026 Performance Amid Strong Market Rally

2026-08-06 08:00:19

Shilpa Medicare Ltd has delivered an exceptional quarterly performance for June 2026, marking a significant upgrade in its financial trend from very positive to outstanding. The pharmaceutical and biotechnology company recorded its highest-ever quarterly revenue and profit metrics, reflecting robust operational efficiency and strong market demand amid a challenging sector backdrop.

Read full news article

View All News